- Nachrichtendetail
-
24.04.2024 16:26:17 - dpa-AFX: *IMMUTEP: PHASE IIB TRIAL SHOWS POSITIVE RESULTS IN FIRST-LINE HNSCC TREATMENT WITH EFTILAGIMOD ALPHA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Xetra | 118,800 | 27.05.24 13:14:23 | -1,200 | -1,00% | 118,600 | 119,600 | 120,000 | 120,000 |
